Internationale PatientenAktuellesKontakt
UNIVERSITÄTSKLINIKENHACETTEPE
Termin
DE
  1. Home
  2. Ärzte
  3. Ass.-Prof. Dr. Melek Tuğçe Yılmaz Aslan
MA

Ass.-Prof. Dr.

Melek Tuğçe Yılmaz Aslan

Radiation Oncology · Onkologische Klinik

Termin vereinbaren

This page is not yet available in Deutsch. The Turkish version is shown below.

Publications

Source: Hacettepe University academic database (AVESİS) · All publications (47) ↗

Articles 33

  1. Does Adding Chemotherapy to Radiotherapy Improve Outcomes in Stage II Nasopharyngeal Carcinoma?KAHVECIOĞLU A., YILMAZ M. T., MOHAMMADIPOUR S., SARI S. Y., CENGİZ M., GÜLLÜ İ., et al.Türk Onkoloji Dergisi, cilt.40, sa.2, ss.112-119, 2025 (ESCI, Scopus, TRDizin)
  2. Challenging the Children's Oncology Group Whole Ventricular Irradiation Atlas: A Call for Standardized GuidelinesYILMAZ ASLAN M. T., KAHVECİOĞLU A., ÇOBAN ÇİFÇİ G., IŞIKAY A. İ., YAZICI G.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, cilt.122, sa.1, ss.164-165, 2025 (SCI-Expanded, Scopus)
  3. Determining Residents' Concerns About Staying Up to Date: Turkish Society for Radiation Oncology-Young Radiation Oncologists' Cross-Sectional National Survey (TROD/GROG 007)Yilmaz M. T., KAHVECİOĞLU A., GÜLTEKİN M., ATALAR B., ÖZYİĞİT G., Selek U.JCO GLOBAL ONCOLOGY, cilt.11, 2025 (ESCI, Scopus)
  4. Evaluating the impact of cardiac substructure dosimetric parameters on survival in lung cancer patients undergoing postoperative radiotherapyYilmaz M. T., HÜRMÜZ P., GÜRLEK E., YILDIZ D., CENGİZ M.STRAHLENTHERAPIE UND ONKOLOGIE, cilt.201, sa.4, ss.452-462, 2025 (SCI-Expanded, Scopus)
  5. Prognostic Impact of Low Muscle Mass and Inflammatory Markers in Stage III Nonsmall Cell Lung Cancer Turkish Oncology Group and Turkish Society of Radiation Oncology Thoracic Cancer Study Group (08-005)Gumustepe E., Yavas G., Kirakli E. K., DİNÇBAŞ H. F., Dilek N., HÜRMÜZ P., et al.AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, cilt.48, sa.2, ss.67-74, 2025 (SCI-Expanded, Scopus)
  6. Analysis of patients with parotid recurrence after parotid-sparing IMRT for nasopharyngeal carcinoma: case series and review of the literatureYÜCE SARI S., Yilmaz M. T., YAZICI G., Mohammadipour S., ÖZYİĞİT G., Gullu İ. H., et al.STRAHLENTHERAPIE UND ONKOLOGIE, cilt.200, sa.12, ss.1057-1065, 2024 (SCI-Expanded, Scopus)
  7. Evaluation of Treatment Outcomes of Prostate Cancer Patients With Lymph Node Metastasis Treated With Definitive RadiotherapyOnal C., Guler O. C., ERPOLAT Ö. P., HÜRMÜZ P., Sutera P., Deek M. P., et al.CLINICAL NUCLEAR MEDICINE, cilt.49, sa.8, 2024 (SCI-Expanded, Scopus)
  8. External Beam Radiotherapy in the Management of Uveal MelanomaYilmaz M. T., YÜCE SARI S., Zorlu F., YAZICI G.CURRENT TREATMENT OPTIONS IN ONCOLOGY, cilt.25, sa.7, ss.932-951, 2024 (SCI-Expanded, Scopus)
  9. Hypo-fractionated Stereotactic Re-Irradiation Outcomes For Recurrent GlioblastomaYilmaz M. T., KAHVECİOĞLU A., Mohammadipur S., Zorlu F., Oge K., KERTMEN N., et al.RADIOTHERAPY AND ONCOLOGY, 2024 (SCI-Expanded, Scopus)
  10. Stereotactic Ablative Radiotherapy Outcomes for Bone-Only Oligometastatic Breast CancerYilmaz M. T., GÜLTEKİN M., YÜCE SARI S., KUMRU T., Kivanc H., ÖZYİĞİT G., et al.RADIOTHERAPY AND ONCOLOGY, 2024 (SCI-Expanded, Scopus)
  11. Predicting Overall Survival for Patients Who Underwent Adjuvant Chemoradiotherapy for Gastric CancerYilmaz M. T., HÜRMÜZ P., DAĞ O., YİĞİT E., Ozyure Y., AVCI H., et al.RADIOTHERAPY AND ONCOLOGY, 2024 (SCI-Expanded, Scopus)
  12. The Impact of Concurrent Chemotherapy on Stage II Nasopharyngeal CarcinomaYilmaz M. T., KAHVECİOĞLU A., Mohammadipour S., CENGİZ M., Gullu I., AKSOY S., et al.RADIOTHERAPY AND ONCOLOGY, 2024 (SCI-Expanded, Scopus)
  13. Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years’ experience of a single centerYilmaz M. T., KAHVECİOĞLU A., YAZICI G., Mohammadipour S., KERTMEN N., Cifci G. C., et al.Journal of Neuro-Oncology, cilt.167, sa.2, ss.295-303, 2024 (SCI-Expanded, Scopus)
  14. Enhanced Radiosensitivity with Hypericum Perforatum in Radiation-induced Radiodermatitis Rat ModelYilmaz M. T., YEDEKÇİ F. Y., YÜCE SARI S., KURTULAN O., CENGİZ M., Zorlu F., et al.TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, cilt.39, ss.337-344, 2024 (ESCI, Scopus, TRDizin)
  15. Intensity-modulated vaginal brachytherapy applicator and single- and multi-channel applicators in vaginal cuff brachytherapyBiltekin F., Akyol H. F., Gültekin M., Yilmaz M. T., Yıldız F.JOURNAL OF CONTEMPORARY BRACHYTHERAPY, cilt.16, sa.2, ss.132-138, 2024 (SCI-Expanded, Scopus)
  16. Testicular metastasis in prostate cancer: A rare case of testicular metastasis diagnosed with Ga-68-PSMA and review of the literatureÖZYİĞİT G., AKDOĞAN B., YILMAZ M. T., GÜNER G., BOZKURT M. F.JOURNAL OF CLINICAL UROLOGY, cilt.17, sa.1, ss.79-82, 2024 (ESCI, Scopus)
  17. Every other day stereotactic radiation therapy for the treatment of uveal melanoma decreases toxicityYAZICI G., KIRATLI H., ÖZYİĞİT G., Sari S., Elmali A., Yilmaz M. T., et al.RADIOTHERAPY AND ONCOLOGY, cilt.176, ss.39-45, 2022 (SCI-Expanded, Scopus)
  18. The addition of pelvic lymph node treatment to prostate bed salvage radiotherapyKAHVECİOĞLU A., Yilmaz M. T., HÜRMÜZ P.The Lancet, cilt.400, sa.10356, ss.884-885, 2022 (SCI-Expanded, Scopus)
  19. Turkish translation and validation of the Xerostomia InventorySari S., Yilmaz M. T., ELMALI A., KILIÇ L., YÜCE D., ÖZYİĞİT G., et al.ARCHIVES OF RHEUMATOLOGY, cilt.37, ss.351-360, 2022 (SCI-Expanded, Scopus, TRDizin)
  20. Pneumonitis Risk in Breast Cancer PatientsYilmaz M. T., GÜLTEKİN M., YILDIZ F.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, cilt.113, sa.2, ss.471-472, 2022 (SCI-Expanded, Scopus)
  21. Stereotactic body radiotherapy boost in patients with cervical cancerGÜLTEKİN M., Yilmaz M. T., Sari S., YILDIZ D., ÖZYİĞİT G., YILDIZ F.JOURNAL OF OBSTETRICS AND GYNAECOLOGY, cilt.42, sa.7, ss.3033-3040, 2022 (SCI-Expanded, Scopus)
  22. Ovarian Carcinoma Presenting With a Large Cervical MassYILMAZ M. T., GÜRLEK E., GÜLTEKİN M., Kahraman K., SALMAN M. C., USUBÜTÜN A., et al.CUREUS JOURNAL OF MEDICAL SCIENCE, cilt.14, sa.1, 2022 (ESCI)
  23. Definitive Chemoradiotherapy Results in Synchronous Oligometastatic Non-small Cell Lung Cancer Patients Turkish Society for Radiation Oncology Group Study (TROD 10-003)DURU BİRGİ S., Akgun Z., HÜRMÜZ P., AKYÜREK S., Saglam E. K., YILMAZ M. T., et al.AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, cilt.45, sa.1, ss.40-47, 2022 (SCI-Expanded, Scopus)
  24. Carbon Ions and Immunotherapy in a Preclinical ModelELMALI A., YILMAZ M. T., YAZICI G.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, cilt.109, sa.5, ss.1658, 2021 (SCI-Expanded, Scopus)
  25. Stereotactic body radiotherapy in patients with early-stage non-small cell lung cancer: Does beam-on time matter?HÜRMÜZ P., CENGİZ M., ÖZYİĞİT G., Akkas E. A., YÜCE D., YILMAZ M. T., et al.JAPANESE JOURNAL OF CLINICAL ONCOLOGY, cilt.50, sa.10, ss.1182-1187, 2020 (SCI-Expanded, Scopus)
  26. Stereotactic radiotherapy in patients with oligometastatic or oligoprogressive gynecological malignancies: a multi-institutional analysisOnal C., GÜLTEKİN M., Oymak E., Guler O. C., YILMAZ M. T., Sari S., et al.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, cilt.30, sa.6, ss.865-872, 2020 (SCI-Expanded, Scopus)
  27. Stereotactic ablative radiotherapy for bone metastasis of gastrointestinal stromal tumor: Case report and review of the literatureYILMAZ M. T., GÜLTEKİN M., YALÇIN Ş., TUNCEL M., Gedikoglu G., YILDIZ F., et al.REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, cilt.25, sa.3, ss.331-335, 2020 (ESCI, Scopus)
  28. Comments on "Risk factors for vertebral compression fracture after spine stereotactic body radiation therapy: Long-term results of a prospective phase 2 study"YILMAZ M. T., HÜRMÜZ P.RADIOTHERAPY AND ONCOLOGY, cilt.145, ss.127, 2020 (SCI-Expanded, Scopus)
  29. FLASH-radiotherapy: A new perspective in immunotherapy era?YILMAZ M. T., HÜRMÜZ P., YAZICI G.RADIOTHERAPY AND ONCOLOGY, cilt.145, ss.137, 2020 (SCI-Expanded, Scopus)
  30. Dosimetric comparison of two different applicators and rectal retraction methods used in inverse optimization-based intracavitary brachytherapy for cervical cancerBİLTEKİN F., GÜLTEKİN M., YILMAZ M. T., YILDIZ F.JOURNAL OF CONTEMPORARY BRACHYTHERAPY, cilt.12, sa.1, ss.35-43, 2020 (SCI-Expanded, Scopus)
  31. Long Term Follow-Up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase II Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer In Regard to Videtic et alYILMAZ M. T., HÜRMÜZ P., CENGİZ M.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, cilt.104, sa.2, ss.466-467, 2019 (SCI-Expanded, Scopus)
  32. The Synergistic Effect of Immune Checkpoint Blockade and Radiotherapy in Recurrent/Metastatic Sinonasal CancerYAZICI G., GÜLLÜ İ. H., CENGİZ M., ELMALI DOĞAN A., YILMAZ M. T., AKSOY S., et al.Cureus, cilt.10, ss.3519, 2018 (ESCI)
  33. Concurrent Immune Checkpoint Inhibitors and Radiation TherapyYILMAZ M. T., HÜRMÜZ P., CENGİZ M.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, cilt.101, sa.4, ss.998, 2018 (SCI-Expanded, Scopus)

Conference papers 14

  1. Reirradiation With Stereotactic Ablative Radiotherapy In Recurrent Head And Neck CancersYİĞİT E., Yilmaz M. T., KAHVECİOĞLU A., YEDEKÇİ F. Y., YÜCE SARI S., CENGİZ M., et al.9th International Congress on Innovative Approaches in Head and Neck Oncology (ICHNO), Barcelona, İspanya, 21 - 23 Mart 2024, (Özet Bildiri)
  2. Reirradiation with Stereotactic Ablative Radiotherapy in Recurrent Nasopharyngeal CarcinomaYilmaz M. T., YİĞİT E., KAHVECİOĞLU A., YEDEKÇİ F. Y., YÜCE SARI S., CENGİZ M., et al.9th International Congress on Innovative Approaches in Head and Neck Oncology (ICHNO), Barcelona, İspanya, 21 - 23 Mart 2024, (Özet Bildiri)
  3. İntrauterin tandem-ovoid ve tandem-ring aplikatörlerin kaynak yükleme paterni açısından karşılaştırılmasıBİLTEKİN F., GÜLTEKİN M., YILMAZ M. T., YILDIZ F., AKYOL H. F.14. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Türkiye, 26 - 30 Kasım 2021, ss.77-78, (Özet Bildiri)
  4. Inverse Planning Intensity-Modulated Radiation Therapy in Chest Wall and Lymphatic Irradiation: Early ResultsBEDÜK ESEN S., YILMAZ M. T., YEDEKÇİ F. Y., YÜCE SARI S., GÜLTEKİN M., ÖZYİĞİT G., et al.60th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, 21 - 24 Ekim 2018, (Tam Metin Bildiri)
  5. Göğüs Duvarı ve Lenfatik Işınlamada Ters Planlamalı Yoğunluk Ayarlı Radyoterapi: Erken Dönem Sonuçlar.BEDÜK Ç. S., YILMAZ M. T., YEDEKÇİ F. Y., YÜCE SARI S., GÜLTEKİN M., ÖZYİĞİT G., et al.13. UROK, Türkiye, 27 Nisan - 01 Mayıs 2018
  6. Metastatik NUT Midline Karsinomunda İmmünoterapi ve Reirradyasyon: Vaka Sunumu.ELMALI DOĞAN A., YILMAZ M. T., AKSOY S., YÜCE SARI S., ÖZYİĞİT G., YAZICI G.13.Ulusal Radyasyon Onkolojisi Kongresi, Türkiye, 27 Nisan - 01 Mayıs 2018, (Tam Metin Bildiri)
  7. Baş-Boyun Melanomlarında Radyoterapi SonuçlarımızYÜCE SARI S., YAZICI G., CENGİZ M., YILMAZ M. T., AKSOY S., GÜLLÜ İ. H., et al.13. ULUSAL RADYASYON ONKOLOJİSİ KONGRESİ, Türkiye, 27 Nisan - 01 Mayıs 2018, (Tam Metin Bildiri)
  8. Endometriyum kanserlerinde kaf brakiterapisinde klasik yaklaşım ile 3-boyutlu planlamanın dozimetrik karşılaştırılmasıGÜLTEKİN M., YILMAZ M. T., BİLTEKİN F., YÜCE D., YÜCE SARI S., AKYOL H. F., et al.
  9. Serviks kanseri brakiterapisinde tandem-ring ve tandem-ovoid aplikatörün dozimetrik olarak karşilaştirilmasiBİLTEKİN F., GÜLTEKİN M., YILMAZ M. T., YILDIZ F.
  10. Evaluation of Prognostic Biomarkers in Stage III Non-Small Cell Lung Cancer Turkish Radiation Oncology Group Lung Cancer Studying GroupGÜMÜŞTEPE E., YAVAŞ G., korkaz kıraklı e., YILMAZ M. T., ÖZLER T., HÜRMÜZ P., et al.
  11. Evaluation of Prognostic Biomarkers in Stage III Non-Small Cell Lung Cancer Turkish Radiation Oncology Group Lung Cancer Studying GroupGÜMÜŞTEPE E., YAVAŞ G., Kirakli E. K., YILMAZ M. T., Özler T., HÜRMÜZ P., et al.
  12. Definitive Chemoradiotherapy in Esophageal Squamous Cell Cancer: A Single Center ExperienceYILMAZ M. T., HÜRMÜZ P., CENGİZ M., YÜCE D., ZORLU A. F., AKYOL H. F., et al.
  13. Results of Reirradiation with Stereotactic Radiotherapy in Recurrent Head and Neck CancerYÜCE SARI S., CENGİZ M., ELMALI DOĞAN A., YILMAZ M. T., YAZICI G., ÖZYİĞİT G.
  14. Meme Kanserli Olgularda Prognostik Evreleme Sisteminin Değerlendirilmesi.BEDÜK Ç. S., YILMAZ M. T., YÜCE D., YÜCE SARI S., GÜLTEKİN M., ÖZYİĞİT G., et al.

Kontakt

Department
Radiation Oncology, Onkologische Klinik

Zuletzt aktualisiert: